We strive to support the communities in which we work. We provide our people with opportunities to devote their time, energy and talent to supporting the causes that matter.
Walgreens raises over $8.7 million through Red Nose Day
Dedicated to championing everyone’s right to be happy and healthy, Walgreens nationwide became the official retailer of red noses in support of the first Red Nose Day USA in 2015.
Organized by Comic Relief UK, which staged the first ever Red Nose Day in 1988, Red Nose Day raises funds for non-profit organizations that help lift children and young people out of poverty.
From the moment the Red Nose Day USA campaign began in April 2015 to its culmination on 21 May 2015, team members across Walgreens came together to raise money for Red Nose Day. With support from customers across the country, Walgreens exceeded its goal and raised over $8.7 million by selling red noses, vendor partner products and generating in-store cash donations in support of the nationwide fundraising campaign.
“Our incredible partnership with the Red Nose Day campaign is one more way that Walgreens can continue to fulfill its purpose – to champion everyone’s right to be happy and healthy,” said Alex Gourlay, Executive Vice President of Walgreens Boots Alliance, Inc. and President of Walgreens.
“We’re absolutely thrilled to have exceeded our fundraising goal, but the real recognition is owed to our customers and Walgreens team members who embraced the spirit of this cause and joined us for a good laugh along the way. Just the simple, silly act of putting on a red nose means that anyone can benefit children in poverty.”
Fighting cancer through our partnership with the EORTC
Since October 2011, Walgreens Boots Alliance has been working in partnership with the EORTC Cancer Research Fund to support the creation of the first pan-European Biobank for colorectal cancer and at fiscal 2015 has raised over $5 million.
Through a great number of fundraising initiatives as well as sponsorship, employees have helped the EORTC Cancer Research Fund to prove the benefits of advanced personalized medicine for colorectal cancer patients.
The project, called SPECTAcolor, which stands for ‘Screening Patients for Efficient Clinical Trial Access’ is the first ever prospective fully annotated tumor samples Biobank and Biomarker analysis platform for genetic profiling of patients suffering from advanced colorectal cancer.
This unique platform develops personalized treatments based on the results of tissue sampling analysis and is supported by a network of over 30 clinical centers in 11 countries. An estimated 600 to 1,000 patients with advanced colorectal cancer are expected to enroll on a yearly basis. By the end of fiscal 2015, more than 740 patients have enrolled since the official start of the Biobank on 20 September 2013.
Walgreens extends relationship with Vitamin Angels to support more children
Walgreens extended its relationship with charity organization Vitamin Angels by increasing its goal to help provide essential vitamins and minerals to around 100 million children and mothers in at-risk populations by 31 December 2017. Walgreens original goal was to help 10 million children and mothers through the partnership.
Since the initiative began in September 2013, for every vitamin or supplement sold to a Walgreens customer, 1 percent of the item cost is donated to Vitamin Angels, who in turn provide vitamins that help prevent blindness and other serious conditions among undernourished children around the world.
By the end of fiscal 2015, Walgreens has raised more than $15 million, and vitamins have reached more than 62 million children since the partnership’s inception. In fiscal 2015, Walgreens raised more than $8 million. Vitamin Angels plans to use future funds to work with partners in 46 countries, including the USA and Canada, to help prevent nutrient deficiencies by providing vitamins to children and mothers.
(Photograph © Matt Dayka/Vitamin Angels)